Patent Rights Protected Despite NBA Approval Delay: Fresh Examination Directed
Patent rights protected despite NBA approval delay, with fresh examination directed.
Accessibility
40 articles
Captcha Blocks, Accessibility Knocks: Will CGPDTM Open the Door?
In the case of Masoom Reza v. The Controller General of Patents, Designs and Trademarks, the dispute centred on whether the IP Office Trade Marks filing and search…
Patent Expired. Damages Pending. Game Still On for Philips.
Philips’ damages decree remains enforceable despite patent expiry, underscoring post-expiry enforcement rights under Indian IP law.
Inventive Step Misjudged? Delhi HC Revives Trident’s Patent Application
Delhi HC revives Trident’s patent application, citing flaws in the inventive step analysis of its air-rich yarn invention.
Delhi High Court Grants Patent Application Restoration After Agent’s Error
Delhi High Court restores Synertec’s patent application, ruling that agent error, not intent, caused the missed Form-18 deadline.
Towards an Inclusive and Accessible IP Society and Ecosystem: Happy International Day of Persons with Disabilities
On this International Day of Persons with Disabilities, we put forth the need for an inclusive IP ecosystem. For many IP attorneys, innovators, and creators with disabilities, accessibility…
Madras High Court Overturns Patent Refusal for Ab Initio’s Data Lineage Invention
Madras High Court patent judgment backs Ab Initio’s data lineage invention, affirming novelty and inventive step in software patents.
Frimline v. K-SMATCO: Delhi HC Rules Firmly in Pharmaceutical Patent Infringement Case
In Frimline v. K-SMATCO, Delhi HC granted interim relief over patent IN 382949, citing strong prima facie infringement of Frimline’s pharmaceutical formulation.
CRI Patentability Affirmed: Madras High Court Rules in Favor of Syngene
Madras HC upholds CRI patentability in Syngene’s case, ruling novel hardware isn’t a prerequisite for protection under Section 3(k).
Pharmacyclics Divisional Patent Application Upheld by Calcutta High Court
Calcutta High Court upholds Pharmacyclics divisional patent application for ibrutinib-anti-CD20 therapy, interpreting Section 16 of the Patents Act, 1970.